United States Vaccine Market, Forecast By Type & Companies

United States Vaccine Market

United States Vaccine Market

Report Description and Highlights The average human life span has grown significantly primarily due to vaccination. Vaccines have transformed public health throughout the world, especially for children. In the United States, among the various diseases like Influenza, Rotavirus, Hepatitis (Hepatitis A and Hepatitis B), Polio, DTap, HIB, Pneumococcal conjugate, Varicella, MMR and HPV, influenza is the most common viral infection. Quadrivalent is the most common flu vaccines in the United States, which was licensed in the year 2012. According to Renub Research, United States Vaccine Market is poised to reach US$ 11.4 Billion by 2026.

United States Vaccine Market

United States Vaccine Market Although influenza can catch anyone anytime in the year, usually it spreads between May to October. So in August National Immunization Awareness day is being celebrated to increase the awareness and the importance of vaccination in the nation. These immunizations awareness and government initiatives have helped to prevent 2-3 million deaths annually according to the World Health Organisation. There is no other health intervention as simple, powerful, and cost-effective as a ‘vaccine’.

In this report, we have studied key players like GlaxoSmithKline, plc, Merck & Co, Sanofi Pasteur and Pfizer, Inc their trends and implication which has given these companies to view in a strategic way. Apart from that, companies are evaluated on parameters like • •

Overviews Revenues

•

• Recent Developments Vaccinations Pipeline & Clinical Trials Request a free sample copy of the report: https://www.renub.com/requestsample-page.php?gturl=united-states-vaccine-market-p.php United States Vaccine Market

United States Vaccine Market Renub Research report titled “United States Vaccine Market By Vaccine Type (Vaccines Market, Immunized Population and Administered Doses), Influenza (Trivalent Flu Vaccine and Quadrivalent Flu Vaccine), Retrovirus, Hepatitis (Hepatitis A and B), Polio, DTap, HIB, Pneumococcal Conjugate, Varicella, MMR and HPV) Vaccines Products and Pipeline, Company Analysis (GlaxoSmithKline, plc, Merck & Co, Sanofi Pasteur and Pfizer, Inc.)� provides an allencompassing analysis on the United States Vaccine Industry.

Request a free Brochure copy of the report: https://www.renub.com/requestbrochure-page.php?gturl=united-states-vaccine-market-p.php United States Vaccine Market

United States Vaccine Market Forecast for United States Vaccine Market Share (%) - by Type (2020 - 2026)

Source: Renub Research Analysis

Note: These are dummy figures; actual data given in the report

United States Vaccine Market

United States Vaccine Market All the 10 Vaccines have been studied from 3 points • • •

Vaccines Market Immunized Population (Infants) Doses of Vaccines Administered

Vaccine Type - The Report Covers the Market, Immunized Population and Administered Doses of all the 10 diseases 1.

3.

5.

7.

9.

Influenza Vaccines 2. Retrovirus Hepatitis A & B 4. Polio DTaP 6. HIB Pneumococcal conjugate 8. Varicella MMR 10. HPV

United States Vaccine Market

United States Vaccine Market Forecast for United States Vaccine Volume Share (%) - by Type (2020 - 2026)

Source: Renub Research Analysis

Note: These are dummy figures; actual data given in the report

United States Vaccine Market

United States Vaccine Market All the company analysis has been covered from 4 Viewpoints • • • •

Overview Recent Developments Revenue Analysis Vaccinations Pipeline & Clinical Trials

Company Analysis • • • •

GlaxoSmithKline, plc Merck & Co Sanofi Pasteur Pfizer, Inc.

United States Vaccine Market

United States Vaccine Market Industry Related Opportunity: China Vaccine Market size is projected to cross over US$ 9 Billion by 2025.

Pediatric Vaccine Market is projected to exceed US$ 48 Billion by the year 2024 Adult Vaccine Market is projected to reach US$ 22 Billion by the year 2024.

Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024.

Global Influenza Vaccine Market is worth more than US$ 5 Billion.

United States Vaccine Market

Contact Us +1-678-302-0700 (US), +91-120-421-9822 (INDIA) Visit us at: https://www.renub.com

Stay with us:

United States Vaccine Market